Lipoti laposachedwa la #WHO la chifuwa chachikulu likuwulula zenizeni: Milandu yatsopano ya TB 8.2 miliyoni idapezeka mu 2023—yapamwamba kwambiri kuyambira pomwe kuyang'aniridwa padziko lonse lapansi kunayamba mu 1995. Kuwonjezeka kumeneku kuchokera pa 7.5 miliyoni mu 2022 kukubwezeretsa TB ngatiwopha matenda opatsirana kwambiri, kupitirira COVID-19.
Komabe, vuto lalikulu kwambiri limabisa kubwereranso kumeneku:kukana maantibayotiki (AMR)WHO ikunena kuti pofika chaka cha 2050, AMR ikhoza kunena kutimiyoyo ya anthu okwana 10 miliyoni pachakapadziko lonse lapansi, pomwe TB yosamva mankhwala (DR-TB) inali chinthu chofunikira kwambiri. Mu 2019 yokha, AMR inapha anthu 1.3 miliyoni—kuposa HIV/AIDS ndi malungo pamodzi—ndipo tsopano ndichifukwa chachitatu chachikulu cha imfa padziko lonse lapansiPopanda kuchitapo kanthu, imfa zambirimbiri chifukwa cha AMR zingafike pa39 miliyoni pofika chaka cha 2050, ndi kutayika kwachuma komwe kumakweraMadola 100 thililiyoni.
Chifukwa Chake Kuzindikira Matenda Panthawi Yake Sikungatheke Kukambirana
Kuchira kwa TB kumadalira kuzindikirika msanga ndi njira zoyenera zochiritsira. Komabe, kugwiritsa ntchito molakwika maantibayotiki kwapangitsa kuti TB yosamva mankhwala ambiri (MDR-TB) ipitirire patsogolo, zomwe zasintha matenda ochiritsika kukhala oopsa. Chodabwitsa n'chakuti:
TB yosamva mankhwala imayambitsa 1/3 ya imfa za AMR padziko lonse lapansi.
Anthu okalamba akukumana ndi kuwonjezeka kwa imfa chifukwa cha AMR(kukwera ndi 80% kuyambira mu 1990 pakati pa okalamba).
Kusintha kwa nyengo kungakhaleKufalikira kwa AMR kukuipiraipira ndi 2.4% pofika 2050, zomwe zimakhudza madera omwe ali ndi ndalama zochepa mosiyanasiyana.
WHO ikupempha mwachangu kuti pakhale zatsopano pakupeza matenda mwachangu kuti athetse kugwiritsa ntchito molakwika komanso kutseka mipata yochizira
Chida Chotsimikizira Matenda Atatu a TB cha Macro & Micro-Test: Zida Zolondola za Nthawi ya AMR
Yankho lathu likugwirizana ndi njira ya WHO yochepetsera AMR pololakuzindikira nthawi imodzi matenda a TB + rifampicin (RIF) + isoniazid (INH) resistance—chofunika kwambiri pochepetsa DR-TB.
Zinthu Zofunika Kwambiri:
Liwiro ndi KulondolaZotsatira zake zimachitika mkati mwa maola 2–2.5 ndipo zimangosinthidwa zokha (maphunziro ochepa amafunika).
Zolinga Zonse:TB: jini la IS6110
Kukana kwa RIF: rpoB (507~533)
Kukana kwa INH: InhA, AhpC, katG 315
Kuzindikira Kwambiri: Imazindikira mabakiteriya ochepa ngati 10/mL (TB) ndi mabakiteriya 150–200/mL kuti ione ngati pali zizindikiro zotsutsa.
Kutsatira WHO: Amakwaniritsa malangizo okhudza kasamalidwe ka DR-TB.
Kugwirizana Kwambiri: Imagwira ntchito ndi makina akuluakulu a PCR (monga Bio-Rad CFX96, SLAN-96P/S).
Chifukwa Chake Izi Ndi Zofunika:
Kuzindikira mwachangu majini okana mankhwala kumaletsa kugwiritsa ntchito mankhwala opha tizilombo molakwika, kumachepetsa kufalikira kwa matendawa,
Kuitana Kuchitapo Kanthu
Kugwirizana kwa kubwereranso kwa chifuwa chachikulu ndi AMR kumafuna zida zomwe zimagwirizanitsa liwiro molondola. Zida zathu zimatseka kusiyana kumeneku—kuonetsetsa kuti chithandizo chikuyamba bwino, nthawi yoyamba.
Dziwani zambiri:
https://www.mmtest.com/mycobacterium-tuberculosis-nucleic-acid-and-rifampicin%ef%bc%8cisoniazid-resistance-product/
Lumikizanani:marketing@mmtest.com
#IVD #PCR #AMRCrisis #Kukana Mankhwala #TB #ENDTB #MDRTB #Kuzindikira #GlobalHealth #WHO #MacroMicroTest
Nthawi yotumizira: Novembala-25-2025